Caisse De Depot Et Placement Du Quebec Ionis Pharmaceuticals Inc Transaction History

Caisse De Depot Et Placement Du Quebec

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$31.71 - $43.0 $6.29 Million - $8.53 Million	198,324 New	198,324 $7.34 Million
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $302,586 - $453,986	-7,118 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $5,345 - $7,111	118 Added 1.69%	7,118 $402,000
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $18,980 - $25,180	-400 Reduced 5.41%	7,000 $332,000
Q2 2020 Aug 14, 2020	BUY	$46.85 - $61.05 $10,962 - $14,285	234 Added 3.27%	7,400 $436,000
Q1 2020 May 14, 2020	BUY	$41.6 - $63.4 $131,705 - $200,724	3,166 Added 79.15%	7,166 $339,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $215,400 - $261,079	4,000 New	4,000 $242,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.16B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.